-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga·05/07/2025 17:06:24
Listen to the news

Gainers

  • Regencell Bioscience (NASDAQ:RGC) shares increased by 25.4% to $189.28 during Wednesday's regular session. The company's market cap stands at $2.4 billion.
  • Hepion Pharmaceuticals (NASDAQ:HEPA) stock increased by 23.37% to $0.4. The company's market cap stands at $4.3 million.
  • Elanco Animal Health (NYSE:ELAN) stock moved upwards by 20.66% to $11.47. The market value of their outstanding shares is at $5.6 billion. The company's, Q1 earnings came out today.
  • Beta Bionics (NASDAQ:BBNX) shares moved upwards by 19.47% to $13.56. The market value of their outstanding shares is at $587.8 million. The company's, Q1 earnings came out yesterday.
  • Phio Pharma (NASDAQ:PHIO) stock rose 18.02% to $2.03. The company's market cap stands at $9.6 million.
  • Halozyme Therapeutics (NASDAQ:HALO) stock moved upwards by 17.77% to $69.94. The market value of their outstanding shares is at $8.6 billion. The company's, Q1 earnings came out yesterday.

Losers

  • Palatin Techs (AMEX:PTN) stock declined by 44.6% to $0.09 during Wednesday's regular session. The market value of their outstanding shares is at $2.4 million.
  • Theriva Biologics (AMEX:TOVX) stock fell 41.43% to $0.8. The company's market cap stands at $2.2 million.
  • Myriad Genetics (NASDAQ:MYGN) stock decreased by 36.46% to $4.62. The company's market cap stands at $425.8 million. The company's, Q1 earnings came out yesterday.
  • Pasithea Therapeutics (NASDAQ:KTTA) shares decreased by 29.61% to $1.07. The company's market cap stands at $2.8 million.
  • AquaBounty Techs (NASDAQ:AQB) shares decreased by 26.03% to $0.7. The market value of their outstanding shares is at $2.6 million.
  • Agilon Health (NYSE:AGL) stock decreased by 24.03% to $3.39. The market value of their outstanding shares is at $1.3 billion. As per the news, the Q1 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.